As previously mentioned, because DPP-4 inhibitors can increase the risk of hypoglycemia when added to insulin or a sulfonylurea, a dose decrease of sulfonylurea and/or insulin should be considered prior to initiation of a DPP-4 inhibitor
N-acetylcysteine and coronavirus disease 2019: may it work as a beneficial preventive and adjuvant therapy
Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: rationale and design of the TRIUMPH registrational clinical trials
The pressure to look 'flawless' Dr Jyoti Aneja (founder of La Grace Luxury Skin Clinic) shared that the rise of high-definition cameras, red carpets, paparazzi and now social media has created an unrelenting pressure to look flawless, at every angle, every moment
We prioritize your safety and well-being every step of the way
Within 18 months of launch, Lilly captured 53% of the US GLP-1 market, fundamentally shifting the competitive dynamics from Novos established dominance